SOPHARMA AD: Sopharma monthly September 2013

opublikowano: 2013-10-09 15:27

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Sopharma_monthly_September_2013.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 129 / 2013
Date of issue: 2013-10-09
Short name of the issuer
SOPHARMA AD
Subject
Sopharma monthly September 2013
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company") notifies that for September 2013 the Company realized an increase of sales revenues of 12% compared to the same period of 2012, including 17% increase of domestic sales and 10% increase of export sales.
During the past nine months Sopharma AD recorded a decrease of sales revenues of 1%, including 6% increase of domestic sales and 3% decrease of export sales compared to the same period of 2012.
Annexes
File Description
Sopharma monthly September 2013.docSopharma monthly September 2013.doc Sopharma monthly September 2013

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-10-09 Ognian Donev Executive Director